Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 2
2007 2
2008 2
2009 5
2010 2
2011 4
2012 8
2013 8
2014 5
2015 9
2016 5
2017 6
2018 3
2019 9
2020 5
2021 10
2022 12
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.
Peñafiel Vicuña AK, Yamazaki Nakashimada M, León Lara X, Mendieta Flores E, Nuñez Núñez ME, Lona-Reyes JC, Hernández Nieto L, Ramírez Vázquez MG, Barroso Santos J, López Iñiguez Á, González Y, Torres M, Lezana Fernández JL, Román Montes CM, Medina-Torres EA, González Serrano E, Bustamante Ogando JC, Lugo Reyes S, Zavaleta Martínez O, Staines Boone AT, Venegas Montoya E, Aguilar Gómez NE, Soudeé C, Jouanguy E, Puel A, Boisson-Dupuis S, Pedraza Sánchez S, Casanova JL, Espinosa Rosales F, Espinosa Padilla S, Bustamante J, Blancas Galicia L. Peñafiel Vicuña AK, et al. Among authors: gonzalez y. J Clin Immunol. 2023 Jan;43(1):123-135. doi: 10.1007/s10875-022-01357-8. Epub 2022 Aug 31. J Clin Immunol. 2023. PMID: 36044171 Free PMC article.
Immunological Aspects of Diagnosis and Management of Childhood Tuberculosis.
Gutiérrez-González LH, Juárez E, Carranza C, Carreto-Binaghi LE, Alejandre A, Cabello-Gutiérrrez C, Gonzalez Y. Gutiérrez-González LH, et al. Among authors: gonzalez y. Infect Drug Resist. 2021 Mar 8;14:929-946. doi: 10.2147/IDR.S295798. eCollection 2021. Infect Drug Resist. 2021. PMID: 33727834 Free PMC article. Review.
Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort.
Sarto J, Ruiz-García R, Guillén N, Ramos-Campoy Ó, Falgàs N, Esteller D, Contador J, Fernández G, González Y, Tort-Merino A, Juncà-Parella J, Bosch B, Borrego-Écija S, Molina-Porcel L, Castellví M, Vergara M, Antonell A, Augé JM, Naranjo L, Sanchez-Valle R, Lladó A, Balasa M. Sarto J, et al. Among authors: gonzalez y. Neurology. 2023 Feb 21;100(8):e860-e873. doi: 10.1212/WNL.0000000000201597. Epub 2022 Nov 30. Neurology. 2023. PMID: 36450604 Free PMC article.
The impact of COVID-19 on patients with asthma.
Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB. Izquierdo JL, et al. Among authors: gonzalez y. Eur Respir J. 2021 Mar 4;57(3):2003142. doi: 10.1183/13993003.03142-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33154029 Free PMC article.
[Childhood eosinophilic pustulosis].
Morales AL, Matheu R, González Y, Yanguas JI, Caballero MC, Torio B, Monzón FJ. Morales AL, et al. Among authors: gonzalez y. Actas Dermosifiliogr. 2005 Jan-Feb;96(1):40-2. doi: 10.1016/s0001-7310(05)73031-3. Actas Dermosifiliogr. 2005. PMID: 16476331 Free article. Spanish.
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, non-randomized, multicenter GEM-SELIBORDARA study.
González-Calle V, Rodríguez-Otero P, Sureda A, De Arriba F, Reinoso M, Ribas P, González-Rodríguez AP, González Y, Oriol A, Martínez-López J, González MS, Hernández MT, Sirvent M, Cedena T, Puig N, Paiva B, Bladé J, Lahuerta JJ, San-Miguel JF, Mateos MV. González-Calle V, et al. Among authors: gonzalez y. Haematologica. 2024 Feb 15. doi: 10.3324/haematol.2023.284089. Online ahead of print. Haematologica. 2024. PMID: 38356463 Free article.
94 results